Viewing Study NCT03495804


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2025-12-25 @ 7:06 PM
Study NCT ID: NCT03495804
Status: UNKNOWN
Last Update Posted: 2018-08-24
First Post: 2018-01-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluation of the Performance of Two Neutral Oral Contrast Agents in CT Enterography
Sponsor: Shandong University
Organization:

Study Overview

Official Title: Evaluation of the Performance of Two Neutral Oral Contrast Agents in CT Enterography (CTE)
Status: UNKNOWN
Status Verified Date: 2018-08
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: CT enterography has become an important tool in the evaluation of small bowel diseases, especially in patients with inflammatory bowel diseases. There are several shortcomings of commonly used isotonic mannitol as an oral contrast agent, such as incident adverse reactions and gases in the gut. However, polyethylene glycol can avoid these drawbacks with a good performance in some pilot experiments.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: